4883 — Modalis Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Modalis Therapeutics, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 146 | -440 | -745 | -2,707 | -2,391 |
| Depreciation | |||||
| Non-Cash Items | 8.69 | 39.7 | -487 | 678 | 40.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 62.4 | -34.4 | 407 | 9.51 | 94.5 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 224 | -377 | -747 | -1,896 | -2,254 |
| Capital Expenditures | -54.3 | -830 | -107 | -197 | -39.7 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -7.49 | -0.296 | 279 | 11.6 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -61.8 | -830 | 172 | -186 | -39.7 |
| Financing Cash Flow Items | -0.212 | -20.3 | -0.001 | -0.911 | -6.85 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2,491 | 2,778 | 72.6 | 63.7 | 1,216 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2,652 | 1,564 | -485 | -2,003 | -1,050 |